PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center for Rhinology and Allergology, Wiesbaden, Germany.\', \'Department of Dermatology and Allergy, University Hospital, Bonn, Germany.\', \'Department of Allergy, Research Institute Hospital 12 de Octubre, Madrid, Spain.\', \'Department of Clinical Immunology, Wrocław Medical University, Poland, ALL-MED Medical research Institute, Wroclaw, Poland.\', \'Comprehensive Allergy Center, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.\', \'MACVIA-France, Montpellier, France.\', \'Swiss Institute of Allergy and Asthma Research (SIAF, University of Zurich, Davos, Switzerland.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/all.14794
?:hasPublicationType
?:journal
  • Allergy
is ?:pmid of
?:pmid
?:pmid
  • 33657648
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all